Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 14, 2024

BUY
$64.37 - $75.65 $7.08 Million - $8.32 Million
110,000 New
110,000 $7.61 Million
Q4 2021

May 03, 2022

BUY
$35.2 - $53.42 $2.64 Million - $4.01 Million
75,000 New
75,000 $3.93 Million
Q1 2020

May 15, 2020

SELL
$12.31 - $33.12 $7.36 Million - $19.8 Million
-598,000 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$7.26 - $38.49 $4.34 Million - $23 Million
598,000 New
598,000 $20.5 Million

Others Institutions Holding ITCI

About Intra-Cellular Therapies, Inc.


  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $6.92B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.